| Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis (NCT05202860) | Merete Haedersdal | 2022-05-09 |
| Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms (NCT05402046) | MelanomaPRO, Russia | 2022-04-23 |
| Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO (NCT05078047) | UNICANCER | 2022-03-08 |
| A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma (NCT05294120) | Memorial Sloan Kettering Cancer Center | 2022-03-03 |
| Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery (NCT05170035) | Bispebjerg Hospital | 2022-02-01 |
| Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma (NCT05188729) | Verrica Pharmaceuticals Inc. | 2022-02-01 |
| Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery (NCT05234658) | Andalusian Network for Design and Translation of Advanced Therapies | 2022-01-21 |
| Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy (NCT05020912) | Case Comprehensive Cancer Center | 2021-12-13 |
| A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer (NCT04916002) | Regeneron Pharmaceuticals | 2021-11-30 |
| Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study (NCT05463757) | Maastricht University Medical Center | 2021-11-01 |
| Laser Treatment of Basal Cell Carcinoma (NCT04936932) | Sciton | 2021-11-01 |
| Intratumoral phIL12 GET (NCT05077033) | Institute of Oncology Ljubljana | 2021-09-28 |
| Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) (NCT04928222) | SkinJect, Inc. | 2021-09-24 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma (NCT06309836) | Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse | 2021-06-23 |
| Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo (NCT04969419) | Momentum Data | 2021-06-18 |
| Personalised Immunotherapy Platform (NCT06536257) | Melanoma Institute Australia | 2021-06-08 |
| RCT Treatment Versus Non Treatment of Low-risk BCCs in Elderly (NCT05110924) | University Hospital, Ghent | 2021-06-01 |
| The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated. (NCT04093401) | University of Wisconsin, Madison | 2021-06-01 |
| Anti-PD1-antibody and Pulsed HHI for Advanced BCC (NCT04679480) | Reinhard Dummer | 2021-02-18 |
| Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment (NCT05581342) | Maastricht University Medical Center | 2021-01-15 |
| Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma (NCT04744935) | Christopher Zachary | 2021-01-13 |
| Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm (NCT04695015) | Peking University | 2020-12-31 |
| Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma (NCT04669808) | Sirnaomics | 2020-12-28 |
| SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein Positivity (NCT04759261) | Trakya University | 2020-12-01 |
| Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer (NCT04410874) | Ivan Litvinov | 2020-11-16 |
| Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor (NCT04416516) | Ascend Biopharmaceuticals Ltd | 2020-07-16 |
| HRQoL Keratinocyte Carcinomas (NCT04814953) | University Hospital, Ghent | 2020-07-01 |
| Skin Tumor Biomarkers by Mass Spectrometry Imaging (NCT06227416) | Bispebjerg Hospital | 2020-06-15 |
| Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies (NCT04349436) | Replimune, Inc. | 2020-05-15 |
| Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation (NCT04795297) | University Hospital, Montpellier | 2020-02-01 |
| Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study (NCT05046262) | Bispebjerg Hospital | 2020-01-08 |
| BCC Excision Revisited (NCT05853315) | Medical University of Vienna | 2019-11-12 |
| A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer (NCT04099446) | ProgenaBiome | 2019-10-01 |
| A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors (NCT03982212) | University of Kansas Medical Center | 2019-07-26 |
| A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma (NCT03534947) | Melanoma Institute Australia | 2019-07-23 |
| Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage (NCT04688749) | Aristotle University Of Thessaloniki | 2019-07-17 |
| CemiplimAb Survivorship Epidemiology (NCT03836105) | Regeneron Pharmaceuticals | 2019-06-27 |
| Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma (NCT03889912) | Regeneron Pharmaceuticals | 2019-04-11 |
| Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma (NCT04066504) | Sun Pharmaceutical Industries Limited | 2019-03-11 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer (NCT03775525) | Genzada Pharmaceuticals USA, Inc. | 2019-03-01 |
| (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC) (NCT03848078) | Maastricht University Medical Center | 2019-02-26 |
| A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors (NCT03734913) | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 2019-01-25 |
| Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma (NCT03521830) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-27 |
| A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma (NCT03714529) | Herlev and Gentofte Hospital | 2018-11-01 |
| Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma (NCT03467789) | Case Comprehensive Cancer Center | 2018-10-01 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488) | Xencor, Inc. | 2018-07-10 |
| T-VEC in Non-melanoma Skin Cancer (NCT03458117) | University of Zurich | 2018-04-19 |
| Topical Vitamin C for Treatment of Basal Cell Cancer (NCT04279535) | Center for Biomedical Research, Inc. | 2018-03-01 |
| How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes (NCT03370861) | Washington University School of Medicine | 2017-11-08 |
| Photographing the Skin During Photodynamic Therapy (NCT03167762) | University of Dundee | 2017-06-22 |
| Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery (NCT03610620) | Julie Dawson | 2017-06-12 |
| Molecular Characterization of Cutaneous Tumors (NCT03092830) | Rabin Medical Center | 2017-03-29 |
| Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma (NCT05041777) | Maastricht University Medical Center | 2017-02-15 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma (NCT03035188) | SRH Wald-Klinikum Gera GmbH | 2017-01-01 |
| Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo (NCT02902822) | Centro Studi Gised | 2016-10-01 |
| Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions (NCT02781389) | University Hospital, Essen | 2016-04-29 |
| Strategies to Promote Skin Health (NCT03237013) | San Diego State University | 2016-02-18 |
| Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas (NCT02639117) | University of Arizona | 2015-11-30 |
| The Role of Melanocyte in Basal Cell Carcinoma (NCT02576769) | Universidad Autonoma de San Luis Potosí | 2015-11-01 |
| Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma (NCT02662244) | University of California, San Diego | 2015-09-01 |
| Using MC1R Genotype to Impact Melanoma Risk Behavior (NCT03509467) | H. Lee Moffitt Cancer Center and Research Institute | 2015-08-03 |
| Utility of the Skin Cancer Quality of Life Impact Tool (NCT02580916) | Oxford University Hospitals NHS Trust | 2015-07-01 |
| Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina (NCT02438644) | Hoffmann-La Roche | 2015-06-30 |
| EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds (NCT02409628) | Neotherix Limited | 2015-04-23 |
| A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC) (NCT02371967) | Hoffmann-La Roche | 2015-04-08 |
| Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery (NCT02321982) | Dartmouth-Hitchcock Medical Center | 2015-02-01 |
| An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence (NCT02296970) | University of Pittsburgh | 2014-12-01 |
| Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) (NCT02667574) | University Hospital, Lille | 2014-11-18 |
| Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold (NCT02059252) | Smart Matrix Limited | 2014-08-01 |
| Video-Based Treatment Options for Basal Cell Carcinoma (NCT02158650) | Emory University | 2014-07-01 |
| Topical Itraconazole in the Treatment of Basal Cell Carcinoma (NCT02120677) | Johns Hopkins University | 2014-05-01 |
| A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma (NCT01898598) | Hoffmann-La Roche | 2014-01-23 |
| Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins (NCT01872130) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas (NCT01815840) | Hoffmann-La Roche | 2013-04-30 |
| Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas (NCT02125669) | Hautklinik Darmstadt | 2012-11-01 |
| An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC) (NCT01604252) | Genentech, Inc. | 2012-06-20 |
| Vismodegib for Treatment of Basal Cell Carcinoma (NCT01543581) | Abel Torres, MD | 2012-05-01 |
| IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 (NCT01609179) | Infinity Pharmaceuticals, Inc. | 2012-03-01 |
| Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology (NCT01540695) | Abramson Cancer Center at Penn Medicine | 2012-02-01 |
| Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors (NCT01529450) | Anne Chang | 2012-02-01 |
| Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? (NCT01770002) | University of California, Davis | 2012-01-01 |
| Microarray Analysis of microRNA Expression in Basal Cell Carcinoma (NCT01498250) | Ruhr University of Bochum | 2011-11-01 |
| Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas (NCT01903239) | Thomas Jefferson University | 2011-11-01 |
| Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma (NCT01358045) | Maastricht University Medical Center | 2011-11-01 |
| Set-back Suture Versus Traditional Vertical Mattress Suture (NCT01773447) | University of California, Davis | 2011-08-01 |
| STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma (NCT01367665) | Hoffmann-La Roche | 2011-07-01 |
| A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma (NCT01327053) | Novartis Pharmaceuticals | 2011-06-29 |
| Clinical Diagnosis of Basal Cell Carcinoma Subtype (NCT01370824) | Maastricht University Medical Center | 2011-06-01 |
| Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery (NCT01298167) | Yale University | 2011-02-01 |
| Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy (NCT01265472) | Rambam Health Care Campus | 2011-01-01 |
| An East Asian Study of LDE225 (NCT01208831) | Novartis Pharmaceuticals | 2010-10-01 |
| Pilot Study of PDL to Treat BCC and SCCIS (NCT01245972) | University of California, San Diego | 2010-08-01 |
| A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma (NCT01160250) | Genentech, Inc. | 2010-07-01 |
| A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions (NCT01014819) | UCSF Benioff Children's Hospital Oakland | 2009-10-01 |
| A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study (NCT00959647) | Genentech, Inc. | 2009-09-03 |
| Electronic Brachytherapy for the Treatment of NMSC (NCT01016899) | Xoft, Inc. | 2009-08-01 |
| Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors (NCT00880308) | Novartis Pharmaceuticals | 2009-03-01 |
| Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer (NCT00836342) | Massachusetts General Hospital | 2009-02-01 |